Shares of Catalyst Pharmaceuticals, Inc. CPRXhave moved up 10.1% in the past one week, against the industry ’s decline of 0.4%. The rise in share price is due to the filling of a new drug application (“NDA”) by the company for itslead pipeline candidate Firdapse. Shares of the company rose 16.4% yesterday.
Catalyst (CPRX) Up on New Drug Application for Firdapse
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться